| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anatomy embroiders function in Purkinje cells
|
Attwell, David
|
|
|
20 |
10 |
p. 793
|
artikel
|
| 2 |
A social dimension for brain health: the mounting pressure
|
The Lancet Neurology,
|
|
|
20 |
10 |
p. 773
|
artikel
|
| 3 |
Autonomic failure: a neglected presentation of Parkinson's disease
|
Fanciulli, Alessandra
|
|
|
20 |
10 |
p. 781-782
|
artikel
|
| 4 |
Buying time for infants with spinal muscular atrophy
|
van der Pol, Ludo
|
|
|
20 |
10 |
p. 777-779
|
artikel
|
| 5 |
Correction to Lancet Neurol 2021; 20: 703–04
|
|
|
|
20 |
10 |
p. e6
|
artikel
|
| 6 |
Correction to Lancet Neurol 2021; 20: 762–72
|
|
|
|
20 |
10 |
p. e6
|
artikel
|
| 7 |
Correction to Lancet Neurol 2021; 20: 687–89
|
|
|
|
20 |
10 |
p. e6
|
artikel
|
| 8 |
Correction to Lancet Neurol 2021; 20: 739–52
|
|
|
|
20 |
10 |
p. e6
|
artikel
|
| 9 |
Crowdfunding for neuromuscular disease treatment: the ethical implications
|
Livingstone, Angus
|
|
|
20 |
10 |
p. 788-789
|
artikel
|
| 10 |
Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial
|
|
|
|
20 |
10 |
p. 842-853
|
artikel
|
| 11 |
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
20 |
10 |
p. 795-820
|
artikel
|
| 12 |
Heart health meets cognitive health: evidence on the role of blood pressure
|
Palta, Priya
|
|
|
20 |
10 |
p. 854-867
|
artikel
|
| 13 |
Integrated approach to stroke burden: are we doing enough?
|
Pandian, Jeyaraj Durai
|
|
|
20 |
10 |
p. 774-775
|
artikel
|
| 14 |
Lessons to be learned in intracerebral haemorrhage research
|
Caso, Valeria
|
|
|
20 |
10 |
p. 779-780
|
artikel
|
| 15 |
Levosimendan for amyotrophic lateral sclerosis
|
Carvalho, Mamede de
|
|
|
20 |
10 |
p. 775-777
|
artikel
|
| 16 |
Michael Moskowitz: solving the puzzle of migraine
|
Samarasekera, Udani
|
|
|
20 |
10 |
p. 790
|
artikel
|
| 17 |
Neuropathology of progressive supranuclear palsy after treatment with tilavonemab
|
Koga, Shunsuke
|
|
|
20 |
10 |
p. 786-787
|
artikel
|
| 18 |
Neuropathology of progressive supranuclear palsy after treatment with tilavonemab – Author's reply
|
Höglinger, Günter U
|
|
|
20 |
10 |
p. 787-788
|
artikel
|
| 19 |
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|
Mercuri, Eugenio
|
|
|
20 |
10 |
p. 832-841
|
artikel
|
| 20 |
Parkinson's disease outside the brain: targeting the autonomic nervous system
|
Sharabi, Yehonatan
|
|
|
20 |
10 |
p. 868-876
|
artikel
|
| 21 |
Pimavanserin and dementia-related psychosis: can HARMONY prevail?
|
Liu, Kathy Y
|
|
|
20 |
10 |
p. 783-784
|
artikel
|
| 22 |
Pratiti (Mimi) Bandopadhayay
|
|
|
|
20 |
10 |
p. 793
|
artikel
|
| 23 |
Pseudomedicine for sports concussions in the USA
|
Bachynski, Kathleen E
|
|
|
20 |
10 |
p. 791-792
|
artikel
|
| 24 |
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
|
Cudkowicz, Merit
|
|
|
20 |
10 |
p. 821-831
|
artikel
|
| 25 |
Thank you to our peer reviewers in 2020
|
Hart, Laura
|
|
|
20 |
10 |
p. 785
|
artikel
|
| 26 |
The social network of functional neurological disorder
|
Stone, Jon
|
|
|
20 |
10 |
p. 794
|
artikel
|
Tijdschrift beschrijving